Atea Pharmaceuticals, Inc. · NASDAQ:AVIR
Murphy Polly A. bought 6,100 Atea Pharmaceuticals, Inc. shares (Form 4/A)
Traded May 18, 2026 · Filed May 21, 2026
On May 18, 2026, Murphy Polly A. (Director) bought 6,100 Atea Pharmaceuticals, Inc. shares at US$4.17 for US$25,437, leaving 92,145 shares. Filed May 21, 2026 (Form 4/A).
- Bought
- 6,100 shares
- Price
- US$4.17
- Value
- US$25,437
- Holding after
- 92,145 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Buy | 6,100 | US$4.17 | 92,145 | Direct |
Source
Related
- Atea Pharmaceuticals, Inc.
- Murphy Polly A.
- Atea Pharmaceuticals, Inc. shareholders
- Form 4 · Murphy Polly A. · Jun 23, 2026
- Form 4 · Murphy Polly A. · May 20, 2026
- Schedule 13G · Tang Capital Management LLC · Oct 6, 2026
- Form 4 · Lucidi Bruno · Jun 23, 2026
- Form 4 · Berger Franklin M · Jun 23, 2026
- Form 4 · Duncan Barbara Gayle · Jun 23, 2026
- Form 4 · Adams Jerome M. · Jun 23, 2026